Literature DB >> 19577757

Does improving mood in depressed patients alter factors that may affect cardiovascular disease risk?

C Barr Taylor1, Ansgar Conrad, Frank H Wilhelm, Diane Strachowski, Anna Khaylis, Eric Neri, Janine Giese-Davis, Walton T Roth, John P Cooke, Helena Kraemer, David Spiegel.   

Abstract

To determine if improvement in mood would ameliorate autonomic dysregulation, HPA dysfunction, typical risk factors and C-reactive protein in depressed patients with elevated cardiovascular disease risk (CVD), 48 depressed participants with elevated cardiovascular risk factors were randomized to a cognitive behavioral intervention (CBT) or a waiting list control (WLC) condition. Twenty non-depressed age and risk-matched controls were also recruited. Traditional risk factors (e.g., lipids, blood pressure) and C-reactive protein were assessed pre- and post-treatment six months later. Subjects also underwent a psychophysiological stress test while cardiovascular physiology was measured. Salivary cortisol was measured during the day and during the psychological stress test. At post-treatment, the CBT subjects were significantly less depressed than WLC subjects. There was no significant difference in change scores on any of the traditional risk factors or C-reactive protein, cortisol measures, or cardiovascular physiology, except for triglyceride levels and heart rate, which were significantly lower in treatment compared to control subjects. The normal controls exhibited no change in the variables measured during the same time. A significant improvement in mood may have little impact on most traditional or atypical risk factors, cortisol or cardiophysiology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19577757      PMCID: PMC2783820          DOI: 10.1016/j.jpsychires.2009.05.006

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  37 in total

Review 1.  How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors.

Authors:  H C Kraemer; E Stice; A Kazdin; D Offord; D Kupfer
Journal:  Am J Psychiatry       Date:  2001-06       Impact factor: 18.112

Review 2.  Systematic review of mental stress-induced myocardial ischaemia.

Authors:  P C Strike; A Steptoe
Journal:  Eur Heart J       Date:  2003-04       Impact factor: 29.983

3.  Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease.

Authors:  R M Carney; K E Freedland; P K Stein; J A Skala; P Hoffman; A S Jaffe
Journal:  Psychosom Med       Date:  2000 Sep-Oct       Impact factor: 4.312

4.  The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity.

Authors:  Kenneth E Freedland; Judith A Skala; Robert M Carney; James M Raczynski; C Barr Taylor; Carlos F Mendes de Leon; Gail Ironson; Marston E Youngblood; K Ranga Rama Krishnan; Richard C Veith
Journal:  Psychosom Med       Date:  2002 Nov-Dec       Impact factor: 4.312

5.  Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change.

Authors:  Jens C Pruessner; Clemens Kirschbaum; Gunther Meinlschmid; Dirk H Hellhammer
Journal:  Psychoneuroendocrinology       Date:  2003-10       Impact factor: 4.905

Review 6.  Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states.

Authors:  P W Gold; G P Chrousos
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

7.  Antidepressive treatment with amitriptyline and paroxetine: effects on saliva cortisol concentrations.

Authors:  Michael Deuschle; Bettina Hamann; Cornelia Meichel; Bertram Krumm; Florian Lederbogen; Anja Kniest; Michael Colla; Isabella Heuser
Journal:  J Clin Psychopharmacol       Date:  2003-04       Impact factor: 3.153

Review 8.  Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.

Authors:  M Bryant Howren; Donald M Lamkin; Jerry Suls
Journal:  Psychosom Med       Date:  2009-02-02       Impact factor: 4.312

9.  Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial.

Authors:  Lisa F Berkman; James Blumenthal; Matthew Burg; Robert M Carney; Diane Catellier; Marie J Cowan; Susan M Czajkowski; Robert DeBusk; James Hosking; Allan Jaffe; Peter G Kaufmann; Pamela Mitchell; James Norman; Lynda H Powell; James M Raczynski; Neil Schneiderman
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

10.  Use of metabolic markers to identify overweight individuals who are insulin resistant.

Authors:  Tracey McLaughlin; Fahim Abbasi; Karen Cheal; James Chu; Cindy Lamendola; Gerald Reaven
Journal:  Ann Intern Med       Date:  2003-11-18       Impact factor: 25.391

View more
  14 in total

1.  Heart Rate Variability, Sleep Quality, and Depression in the Context of Chronic Stress.

Authors:  Chelsea da Estrela; Jennifer McGrath; Linda Booij; Jean-Philippe Gouin
Journal:  Ann Behav Med       Date:  2021-03-16

Review 2.  Heartache and heartbreak--the link between depression and cardiovascular disease.

Authors:  Charles B Nemeroff; Pascal J Goldschmidt-Clermont
Journal:  Nat Rev Cardiol       Date:  2012-06-26       Impact factor: 32.419

3.  Psychosocial Interventions and Immune System Function: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

Authors:  Grant S Shields; Chandler M Spahr; George M Slavich
Journal:  JAMA Psychiatry       Date:  2020-10-01       Impact factor: 21.596

4.  Effect of improved fitness beyond weight loss on cardiovascular risk factors in individuals with type 2 diabetes in the Look AHEAD study.

Authors:  Bethany Barone Gibbs; Frederick L Brancati; Haiying Chen; Mace Coday; John M Jakicic; Cora E Lewis; Kerry J Stewart; Jeanne M Clark
Journal:  Eur J Prev Cardiol       Date:  2012-09-25       Impact factor: 7.804

5.  Increased inflammation predicts nine-year change in major depressive disorder diagnostic status.

Authors:  Nur Hani Zainal; Michelle G Newman
Journal:  J Abnorm Psychol       Date:  2021-10-07

Review 6.  Why Does Psychotherapy Work and for Whom? Hormonal Answers.

Authors:  Susanne Fischer; Sigal Zilcha-Mano
Journal:  Biomedicines       Date:  2022-06-09

Review 7.  From Heartbreak to Heart Disease: A Narrative Review on Depression as an Adjunct to Cardiovascular Disease.

Authors:  Jahanzeb Malik; Hamid Sharif Khan; Faizan Younus; Muhammad Shoaib
Journal:  Pulse (Basel)       Date:  2021-05-31

8.  High cardiac vagal control protects against future depressive symptoms under conditions of high social support.

Authors:  Henrik Hopp; Amanda J Shallcross; Brett Q Ford; Allison S Troy; Frank H Wilhelm; Iris B Mauss
Journal:  Biol Psychol       Date:  2013-01-23       Impact factor: 3.251

9.  Behavioral activation therapy for depression is associated with a reduction in the concentration of circulating quinolinic acid.

Authors:  Jonathan Savitz; Bart N Ford; Hung-Wen Yeh; Elisabeth Akeman; Kelly Cosgrove; Ashley N Clausen; Christopher Martell; Namik Kirlic; Jessica Santiago; T Kent Teague; Michael R Irwin; Martin P Paulus; Robin L Aupperle
Journal:  Psychol Med       Date:  2020-11-25       Impact factor: 10.592

10.  Treatment of affective disorders in cardiac disease.

Authors:  Nicole Mavrides; Charles B Nemeroff
Journal:  Dialogues Clin Neurosci       Date:  2015-06       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.